# The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

> **NCT05836987** · PHASE3 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 5350 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** AFSW Guided DOAC
- **DRUG:** Continuous DOAC therapy

## Key facts

- **NCT ID:** NCT05836987
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-13
- **Primary completion:** 2029-07-31
- **Final completion:** 2029-07-31
- **Target enrollment:** 5350 (ESTIMATED)
- **Last updated:** 2026-04-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05836987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05836987, "The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05836987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*